Old and new determinants in the regulation of energy expenditure

Journal of Endocrinological Investigation

Volumn 25, Issue 10, 2002, Pages 862-866

  Russell, A P ^a   Giacobino, Jean Paul ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Energy expenditure; Obesity; Uncoupling protein; 3 Adrenoceptor

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; ANTIOBESITY AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CL 316249; FATTY ACID; GLUCOSE; GUANOSINE DIPHOSPHATE; LEPTIN; MESSENGER RNA; PURINE NUCLEOTIDE; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3; CARRIER PROTEIN; ION CHANNEL; MEMBRANE PROTEIN; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3;

ADIPOCYTE; BASAL METABOLIC RATE; BODY COMPOSITION; BREATHING; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CELL ISOLATION; CELL MEMBRANE POTENTIAL; COLD EXPOSURE; CONTROLLED STUDY; DIET; DIET RESTRICTION; DRUG EFFECT; DRUG TARGETING; ENERGY EXPENDITURE; EXERCISE; FAST MUSCLE FIBER; GENE EXPRESSION; GLUCOSE TRANSPORT; HUMAN; KNOCKOUT MOUSE; LIPOLYSIS; MITOCHONDRIAL MEMBRANE; MUSCLE ATROPHY; MUSCLE CONTRACTION; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; PROTEIN EXPRESSION; PROTON TRANSPORT; REVIEW; SKELETAL MUSCLE; SLOW MUSCLE FIBER; THERMOGENESIS; THERMOREGULATION; WEIGHT GAIN; WHITE ADIPOSE TISSUE; WILD TYPE; ANIMAL; ENERGY METABOLISM; PHYSIOLOGY;

ANIMALS; CARRIER PROTEINS; ENERGY METABOLISM; HUMANS; ION CHANNELS; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0036860363     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344049     Document Type: Review

References (55)

1. Cannon B., Nedergaard J. Nonshivering thermogenesis and brown adipose tissue. In: Blatteis C.M. (Ed.), Physiology and Pathophysiology of Temperature Regulation. World Scientific, Memphis, 1998, p. 63.
2. Rothwell N.J., Stock M.J. A role for brown adipose tissue in diet-induced thermogenesis. Nature 1979, 281: 31-35.
3. Cannon B., Nedergaard J. The biochemistry of an inefficient tissue: Brown adipose tissue. Essays Biochem. 1985, 20: 110-164.
4. Enerback S., Jacobson A., Simpson E.M. et al. Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese. Nature 1997, 387: 90-94.
5. Cunningham S., Leslie P., Hopwood D. et al. The characterization and energetic potential of brown adipose tissue in man. Clin. Sci. (Lond.) 1985, 69: 343-348.
6. Lean M.E., James W.P., Jennings G., Trayhurn P. Brown adipose tissue uncoupling protein content in human infants, children and adults. Clin. Sci. (Lond.) 1986, 71: 291-297.
7. Emorine L.J., Marullo S., Briend-Sutren M.M. et al. Molecular characterization of the human beta 3-adrenergic receptor. Science 1989, 245: 1118-1121.
8. Muzzin P., Revelli J.P., Kuhne F. et al. An adipose tissue-specific beta-adrenergic receptor. Molecular cloning and down-regulation in obesity. J. Biol. Chem. 1991, 266: 24053-24058.
9. Giacobino J.P. Beta 3-adrenoceptor: An update. Eur. J. Endocrinol. 1995, 132: 377-385.
10. Collins S., Daniel K.E., Rohlfs E.M., Ramkumar V., Taylor I.L., Gettys T.W. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol. Endocrinol. 1994, 8: 518-527.
11. Revelli J.P., Preitner F., Samec S. et al. Targeted gene disruption reveals a leptin-independent role for the mouse beta3-adrenoceptor in the regulation of body composition. J. Clin. Invest. 1997, 100: 1098-1106.
12. Cousin B., Bascands-Viguerie N., Kassis N. et al. Cellular changes during cold acclimatation in adipose tissues. J. Cell. Physiol. 1996, 167: 285-289.
13. Collins S., Daniel K.W., Petro A.E., Surwit R.S. Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology 1997, 138: 405-413.
14. Ghorbani M., Claus T.H., Himms-Hagen J. Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Biochem. Pharmacol. 1997, 54: 121-131.
15. Ghorbani M., Himms-Hagen J. Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int. J. Obes. Relat. Metab. Disord. 1997, 21: 465-475.
16. Guerra C., Koza R.A., Yamashita H., Walsh K., Kozak L.P. Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J. Clin. Invest. 1998, 102: 412-420.
17. Himms-Hagen J., Melnyk A., Zingaretti M.C., Ceresi E., Barbatelli G., Cinti S. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes. Am. J. Physiol. Cell Physiol. 2000, 279: C670-C681.
18. Deng C., Paoloni-Giacobino A., Kuehne F. et al. Respective degree of expression of beta 1-, beta 2- and beta 3-adrenoceptors in human brown and white adipose tissues. Br. J. Pharmacol. 1996, 118: 929-934.
19. Hoffstedt J., Lonqvist F., Shimizu M., Blaak E., Arner P. Effects of several putative beta 3-adrenoceptor agonists on lipolysis in human omental adipocytes. Int. J. Obes. Relat. Metab. Disord. 1996, 20: 428-434.
20. Tavernier G., Barbe, P., Galitzky J. et al. Expression of beta3-adrenoceptors with low lipolytic action in human subcutaneous white adipocytes. J. Lipid Res. 1996, 37: 87-97.
21. Konkar A.A., Zhia Y., Granneman J.G. Beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue. Mol. Pharmacol. 2000, 57: 252-258.
22. Sennitt M.V., Kaumann A.J., Molenaar P. et al. The contribution of classical (beta 1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities. J. Pharmacol. Exp. Ther. 1998, 285: 1084-1095.
23. Clement K., Vaisse C., Manning B.S. et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N. Engl. J. Med. 1995, 333: 352-354.
24. Walston, J., Silver K., Bogardus, C. et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N. Engl. J. Med. 1995, 333: 343-347.
25. Widen E., Lehto M., Kanninen T., Walston, J., Shuldiner A.R., Groop L.C. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N. Engl. J. Med. 1995, 333: 348-351.
26. Shuldiner A.R., Sabra, M. Trp64Arg beta3-adrenoceptor: When does a candidate gene become a disease-susceptibility gene? Obes. Res. 2001, 9: 806-809.
27. Collins S., Kuhn C.M., Petro, A.E., Swick A.G., Chrunyk B.A., Surwit R.S. Role of leptin in fat regulation. Nature 1996, 380: 677.
28. Scarpace P.J., Matheny, M., Pollock B.H., Tumer N. Leptin increases uncoupling protein expression and energy expenditure. Am. J. Physiol. 1997, 273: E226-E230.
29. Satoh N., Ogawa Y., Katsuura G. et al. Sympathetic activation of leptin via the ventromedial hypothalamus: Leptin-induced increase in catecholamine secretion. Diabetes 1999, 48: 1787-1793.
30. Boss O., Samec S., Paoloni-Giacobino A. et al. Uncoupling protein-3: A new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett. 1997, 408: 39-42.
31. Fleury C., Neverova M., Collins S. et al. Uncoupling protein-2: A novel gene linked to obesity and hyperinsulinemia. Nat. Genet. 1997, 15: 269-272.
32. Boss O., Muzzin P., Giacobino J.P. The uncoupling proteins, a review. Eur. J. Endocrinol. 1998, 139: 1-9.
33. Muzzin P., Boss O., Giacobino J.P. Uncoupling protein 3: Its possible biological role and mode of regulation in rodents and humans. J. Bioenerg. Biomembr. 1999, 31: 467-473.
34. Boss O., Hagen T., Lowell B.B. Uncoupling proteins 2 and 3: Potential regulators of mitochondrial energy metabolism. Diabetes 2000, 49: 143-156.
35. Echtay K.S., Winkler E., Frischmuth K., Klingenberg M. Uncoupling proteins 2 and 3 are highly active H(+) transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone). Proc. Natl. Acad. Sci. USA 2001, 98: 1416-1421.
36. Harper J.A., Stuart J.A., Jakobsons M.B. et al. Artifactual uncoupling by uncoupling protein 3 in yeast mitochondria at the concentrations found in mouse and rat skeletal-muscle mitochondria. Biochem. J. 2002, 361: 49-56.
37. Boss O., Samec S., Kuhne F. et al. Uncoupling protein-3 expression in rodent skeletal muscle is modulated by food intake but not by changes in environmental temperature. J. Biol. Chem. 1998; 273: 5-8.
38. Clapham J.C., Arch J.R., Chapman H. et al. Mice expressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000, 406: 415-418.
39. Cadenas S., Echtay K.S., Harper J.A. et al. The basal proton conductance of skeletal muscle mitochondria from transgenic mice overexpressing or lacking uncoupling protein-3. J. Biol. Chem. 2002, 277: 2773-2778.
40. Skulachev V.P. Uncoupling: New approaches to an old problem of bioenergetics. Biochim. Biophys. Acta 1998, 1363: 100-124.
41. Vidal-Puig A.J., Grujic D., Zhang C.Y. et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J. Biol. Chem. 2000, 275: 16258-16266.
42. Echtay K.S., Roussel D., St-Pierre J. et al. Superoxide activates mitochondrial uncoupling proteins. Nature 2002, 415: 96-99.
43. Schrauwen P., Saris W.H., Hesselink M.K. An alternative function for human uncoupling protein 3: Protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB. J. 2001, 15: 2497-2502.
44. Samec S., Seydoux J., Dulloo A.G. Role of UCP homologues in skeletal muscles and brown adipose tissue: Mediators of thermogenesis or regulators of lipids as fuel substrate? FASEB. J. 1998, 12: 715-724.
45. Hayashi T., Hirshman M.F., Kurth E.J., Winder W.W., Goodyear L.J. Evidence for 5′ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998, 47: 1369-1373.
46. Zhou M., Lin B.Z., Coughlin S., Vallega G., Pilch P.F. UCP-3 expression in skeletal muscle: Effects of exercise, hypoxia, and AMP-activated protein kinase. Am. J. Physiol. Endocrinol. Metab. 200, 279: E622-E629.
47. Cros M.T., Kushmerick M.J. Chemical energetics of slow- and fast-twitch muscles of the mouse. J. Gen. Physiol. 1982, 79: 147-166.
48. Kushmerick M.J., Meyer R.A., Brown T.R. Regulation of oxygen consumption in fast- and slow-twitch muscle. Am. J. Physiol. 1992; 263: C598-C606.
49. Hesselink M.K., Keizer H.A., Borghouts L.B. et al. Protein expression of UCP3 differs between human type 1, type 2a, and type 2b fibers. FASEB. J. 2001, 15: 1071-1073.
50. Schrauwen P., Troost F.J., Xia J., Ravussin E., Saris W.H. Skeletal muscle UCP2 and UCP3 expression in trained and untrained male subjects. Int. J. Obes. Relat. Metab. Disord. 1999, 23: 966-972.
51. 2 kinetics: The effect of training status, fibre type, UCP3 mRNA and citrate synthase activity. Int. J. Obes. Relat. Metab. Disord. 2002, 26: 157-164.
52. Sala E., Roca, J., Marrades R.M. et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1999, 159: 1726-1734.
53. Mador M.J., Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir. Res. 2001, 2: 216-224.
54. Lanouette C.M., Giacobino J.P., Perusse L. et al. Association between uncoupling protein 3 gene and obesity-related phenotypes in the Quebec Family Study. Mol. Med. 2001, 7: 433-441.
55. Lanouette C.M., Chagnon Y.C., Rice T. et al. Uncoupling protein 3 gene is associated with body composition changes with training in HERITAGE study. J. Appl. Physiol. 2002, 92: 1111-1118.